pCas9-EcRT-Z3-Kan
(Plasmid
#232096)
-
PurposeYeast CEN plasmid for estradiol-inducible expression of spCas9 and Ec86 reverse transcriptase.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 232096 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCas9-EcRT-GAL-Kan
-
Vector typeYeast Expression, CRISPR
-
Selectable markersKanamycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameZ3 promoter and Z3EV transcription factor
-
SpeciesSynthetic
- Promoter Z3
Cloning Information
- Cloning method Gibson Cloning
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byDavid Botstein, pRS416-yZ3EV-Z3pr (Addgene Plasmid #69099)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The GAL1-GAL10 promoter driving expression of SpCas9 and Ec86 RT in pCas9-EcRT-GAL-Kan was swapped with an estradiol-inducible Z3 promoter and the Z3EV transcription factor was inserterted into the Mph1103I site. Please visit https://doi.org/10.1101/2024.08.06.606807 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCas9-EcRT-Z3-Kan was a gift from Jeffrey Lewis (Addgene plasmid # 232096 ; http://n2t.net/addgene:232096 ; RRID:Addgene_232096) -
For your References section:
Improved vectors for retron-mediated CRISPR-Cas9 genome editing in Saccharomyces cerevisiae. Stuecker TN, Hood SE, Pineda JM, Lenaduwe S, Winter J, Sadhu MJ, Lewis JA. bioRxiv [Preprint]. 2024 Aug 7:2024.08.06.606807. doi: 10.1101/2024.08.06.606807. 10.1101/2024.08.06.606807 PubMed 39149293